- Supported exchanges /
- SHE /
- 002653.SHE
Xizang Haisco Pharmaceutical Group Co Ltd (002653 SHE) stock market data APIs
Haisco Pharmaceutical Group Co., Ltd. research, develops, manufactures, and sells pharmaceuticals in China. The company offers cycloporol, dolasetron mesylate, polyene phosphatidylcholine, compound amino acid, and methylprednisolone sodium injections, as well as flupenthixol melitracen tablets. It offers its products in various therapeutic fields, including anesthesia, parenteral nutrition, tumor antiemetic, liver, gallbladder digestion, antibiotics, cardiovascular, and cerebrovascular. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Shannan, China.
Xizang Haisco Pharmaceutical Group Co Ltd Financial Data Overview
39.64 | |
40.66 | |
- | |
40.66 | |
37.72 | |
18.3892-40.66 | |
44 164 M | |
113.2571 | |
1 114 M | |
3 672 M | |
0.0656 | |
0.0093 | |
0.082 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Xizang Haisco Pharmaceutical Group Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 3 672 M
- EBITDA 627 M
- Earnings Per Share 0.35
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Xizang Haisco Pharmaceutical Group Co Ltd Earnings via APIs
- Latest Release 2024-08-16
- EPS/Forecast NaN
Get Xizang Haisco Pharmaceutical Group Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: